This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Shripad Venkatraman Bhagwat
Introduction
Shripad Venkatraman Bhagwat is a notable inventor based in Carmel, Indiana. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on the inhibition of extracellular-signal-regulated kinase (ERK), which plays a crucial role in cancer progression.
Latest Patents
Bhagwat holds a patent for thieno[2,3-c]pyrrol-4-one compounds that inhibit the activity of ERK. This invention may provide new avenues for cancer treatment, showcasing his commitment to advancing medical science. He has 1 patent to his name, reflecting his innovative approach to addressing complex health challenges.
Career Highlights
Currently, Bhagwat is employed at Eli Lilly and Company, a leading pharmaceutical firm known for its dedication to improving patient outcomes. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable coworkers is Sajan Joseph, with whom he collaborates on various projects aimed at enhancing cancer therapies. Their combined expertise fosters an environment of innovation and progress within their research initiatives.
Conclusion
Shripad Venkatraman Bhagwat's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to cancer treatment through his patented inventions highlight the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile